Economic Environment and Competitive Risks in the European Probiotics Market
First written in FY2017-Q1. 24 of 26 entries say "Restated". Latest entry: FY2024-Q2.
The whole theme swung hardest in 2022: 105 of 134 companies on the "Worse" side.
65 other companies' latest entry also says "Restated".
- FY2024-Q2RestatedAnnual report
「Meanwhile, although the company does not operate in either Russia or Ukraine, it will continue to monitor the potential impact of the prolonged Russia-Ukraine conflict on Europe as a whole.」
The company continues to monitor the impact of the prolonged Russia-Ukraine conflict on Europe as a whole. - FY2024-Q1RestatedAnnual report
「Meanwhile, although the company does not operate in either Russia or Ukraine, it will continue to monitor the potential impact of the prolonged Russia-Ukraine conflict on Europe as a whole.」
The company continues to monitor the impact of the prolonged Russia-Ukraine conflict on Europe as a whole. - FY2023-Q3RestatedAnnual report
「Meanwhile, although the company does not operate in either Russia or Ukraine, it will continue to monitor the potential impact of the prolonged Russia-Ukraine conflict on Europe as a whole.」
The company continues to monitor the impact of the prolonged Russia-Ukraine conflict on Europe as a whole. - FY2023-Q2RestatedAnnual report
「Meanwhile, although the company does not operate in either Russia or Ukraine, it will continue to monitor the potential impact of the prolonged Russia-Ukraine conflict on Europe as a whole.」
The company continues to monitor the impact of the prolonged Russia-Ukraine conflict on Europe as a whole. - FY2023-Q1WorsenedAnnual report
「Meanwhile, although the company does not operate in either Russia or Ukraine, it will continue to monitor the potential impact of the prolonged Russia-Ukraine conflict on Europe as a whole.」
A new disclosure notes that the company is monitoring the impact of the prolonged Russia-Ukraine conflict on Europe as a whole. - FY2022-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Against the backdrop of stringent regulations and a challenging sales environment in Europe, the company continues its sales activities tailored to market characteristics and initiatives aimed at sustainable growth. - FY2022-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Against the backdrop of stringent regulations and a challenging sales environment in Europe, the company continues its sales activities tailored to market characteristics and initiatives aimed at sustainable growth. - FY2022-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Against the backdrop of strict regulations in Europe and challenges in obtaining approval for health claims, the company continues sales activities suited to the characteristics of each market and initiatives toward sustainable growth. - FY2021RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
The company continues sales activities suited to the characteristics of each market amid strict regulations in Europe and challenges in obtaining approval for health claims. - FY2021-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
The company continues sales activities suited to the characteristics of each market amid strict regulations in Europe and challenges in obtaining approval for health claims. - FY2021-Q1RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Under Europe's strict regulations and difficult sales conditions, the company continues initiatives toward approval of health claims and sales activities suited to the characteristics of each market. - FY2020RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued strict regulations and difficult sales conditions in Europe, the company continues initiatives toward approval of health claims and sales activities suited to the characteristics of each market. - FY2020-Q3RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued strict regulations and difficult sales conditions in Europe, the company continues initiatives toward approval of health claims and sales activities suited to the characteristics of each market. - FY2020-Q2RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued strict regulations and difficult sales conditions in Europe, the company continues sales activities suited to the characteristics of each market and initiatives toward sustainable growth. - FY2019RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we are pursuing various initiatives toward approval of health claims. In this environment, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued strict regulations and difficult sales conditions in Europe, the company continues sales activities suited to the characteristics of each market and initiatives toward approval of health claims. - FY2019-Q3RestatedAnnual report
「Amid difficult sales conditions, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued difficult sales conditions in Europe and other regions, the company continues sales activities suited to the characteristics of each market. - FY2019-Q2RestatedAnnual report
「Amid difficult sales conditions, we sought sustainable growth by developing sales activities suited to the characteristics of each market through our operations in each country.」
Amid continued difficult sales conditions in Europe and other regions, the company continues sales activities suited to the characteristics of each market. - FY2019-Q1RestatedAnnual report
「Amid difficult sales conditions, we sought sustainable growth by developing business activities suited to the characteristics of each market through our operations in each country.」
Amid continued difficult sales conditions in Europe and other regions, the company continues business activities suited to the characteristics of each market. - FY2018RestatedAnnual report
「In Europe, amid strict regulations on activities to promote probiotics, we worked to increase sales while pursuing various initiatives toward approval of health claims.」
The company continues its initiatives amid strict regulations in Europe and ongoing challenges in obtaining approval for health claims. - FY2018-Q3RestatedAnnual report
「Amid difficult sales conditions, we sought sustainable growth by developing business activities suited to the characteristics of each market through our operations in each country.」
Amid continued difficult sales conditions in Europe and other regions, the company continues business activities suited to the characteristics of each market. - FY2018-Q2RestatedAnnual report
「Amid unstable regional economies and difficult sales conditions, we sought sustainable growth by developing business activities suited to the characteristics of each market through our operations in each country.」
The company states that unstable regional economies and difficult sales conditions have continued in Europe. - FY2018-Q1RestatedAnnual report
「Amid unstable regional economies and difficult sales conditions, we sought sustainable growth by developing business activities suited to the characteristics of each market through our operations in each country.」
The company states that unstable regional economies and difficult sales conditions have continued in Europe. - FY2017RestatedAnnual report
「The European probiotics market continues to be affected by difficult local economic conditions, while competition with competitors continues.」
The company continues to describe the difficult economic environment and ongoing competition in Europe. - FY2017-Q3RestatedAnnual report
「The European probiotics market continues to be affected by difficult local economic conditions, while competition with competitors continues.」
The company continues to describe the difficult economic environment and ongoing competition in the European probiotics market. - FY2017-Q2RestatedAnnual report
「The European probiotics market continues to be affected by difficult local economic conditions, while competition with competitors continues.」
The company continues to describe the difficult economic environment and ongoing competition in the European probiotics market. - FY2017-Q1First statedAnnual report
「The European probiotics market continues to be affected by difficult local economic conditions, while intense competition with competitors continues.」
The company describes the continued difficult market environment and intensifying competition in Europe as conditions affecting its overseas business.